Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation

European Journal of Dermatology

Volumn 19, Issue 4, 2009, Pages 333-336

  Morais, Paulo ^a,b   Mota, Alberto ^a,b   Baudrier, Teresa ^a,b   Lopes, José Manuel ^a,b   Cerqueira, Rita ^c   Tavares, Purificação ^c   Azevedo, Filomena ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c CGC GENETICS   (Portugal)

Author keywords

Bullous congenital ichthyosiform erythroderma; Epidermolytic hyperkeratosis; KRT1; KRT10; Palmoplantar keratoderma; Retinoids

Indexed keywords

2 HYDROXYACID; CALCIPOTRIOL; CEFUROXIME AXETIL; CYTOKERATIN 10; ETRETIN; FLUCLOXACILLIN; FUSIDIC ACID; SALICYLIC ACID; UREA;

ANAMNESIS; ARTICLE; BLISTER; CASE REPORT; CHILD; CLINICAL FEATURE; DESQUAMATION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; EPIDERMOLYTIC HYPERKERATOSIS; ERYTHEMA; ERYTHRODERMA; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; PALMOPLANTAR KERATODERMA; SCHOOL CHILD; SKIN BIOPSY; SKIN INFECTION;

CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; KERATIN-10; KERATODERMA, PALMOPLANTAR; MUTATION;

EID: 67650908484     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2009.0684     Document Type: Article

References (25)

1. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130: 1026-1035
2. Nikolski P. Contribution à l'étude des anomalies congènitales de keratinisation. Comptes-Rèndus XII Congres Int Medicine. Moscuo 1897; IV: 433-442
3. Brocq L. Erythrodermie congénitale ichthyosiforme avec hyperépidermotrophie. Ann Derm Syphiligr 1902; 3: 1-31.
4. Frost P, Van Scott EJ. Ichthyosiform dermatoses. Classification based on anatomic and biometric observation. Arch Dermatol 1966; 94: 113-126
5. Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol 2003; 4: 347-364
6. DiGiovanna JJ, Bale SJ. Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol 1994; 102: 390-394
7. Virtanen M, Smith SK, Gedde-Dahl Jr T, Vahlquist A, Bowden PE. Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis. J Invest Dermatol 2003; 121: 1013-1020 (Pubitemid 37430967)
8. Virtanen M. On keratin mutations in epidermolytic hyperkeratosis and the regulation of keratin expression by retinoids. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1051, Uppsala, 2001 (45 pp.).
9. Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Lane EB, Eady RA. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99: 19-26.
10. Bale SJ, Compton JG, DiGiovanna JJ. Epidermolytic hyperkeratosis. Semin Dermatol 1993; 12: 202-209
11. Kwak J, Maverakis E. Epidermolytic hyperkeratosis. Dermatol Online J 2006; 12: 6.
12. Müller FB, Huber M, Kinaciyan T, Hausser I, Schaffrath C, Krieg T, Hohl D, Korge BP, Arin MJ. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis. Hum Mol Genet 2006; 15: 1133-1141
13. Arin MJ, Longley MA, Anton-Lamprecht I, Kurze G, Huber M, Hohl D, Rothnagel JA, Roop DR. A novel substitution in keratin 10 in epidermolytic hyperkeratosis. J Invest Dermatol 1999; 112: 506-508 (Pubitemid 29171942)
14. Virtanen M, Gedde-Dahl Jr T, Mörk NJ, Leigh I, Bowden PE, Vahlquist A. Phenotype/ genotype correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy. Acta Derm Venereol 2001; 81: 163-170 (Pubitemid 32800459)
15. McLean WH, Morley SM, Higgins C, Bowden PE, White M, Leigh IM, Lane EB. Novel and recurrent mutations in keratin 10 causing bullous congenital ichthyosiform erythroderma. Exp Dermatol 1999; 8: 120-123 (Pubitemid 29191364)
16. Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet 1999; 85: 330-333 (Pubitemid 29339957)
17. Paller AS. Expanding our concepts of mosaic disorders of skin. Arch Dermatol 2001; 137: 1236-1238
18. Chassaing N, Kanitakis J, Sportich S, Cordier-Alex MP, Titeux M, Calvas P, Claudy A, Berbis P, Hovnanian A. Generalized epidermolytic hyperkeratosis in two unrelated children from parents with localized linear form, and prenatal diagnosis. J Invest Dermatol 2006; 126: 2715-2717 (Pubitemid 44764056)
19. Reddy BS, Thadeus J, Kumar SK, Jaishanker T, Garg BR. Generalized epidermolytic hyperkeratosis in a child born to a parent with systematized epidermolytic linear epidermal nevus. Int J Dermatol 1997; 36: 198-200. (Pubitemid 27208315)
20. Rothnagel JA, Longley NA, Holder RA, Küster W, Roop DR. Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing. J Invest Dermatol 1994; 102: 13-16 (Pubitemid 24039556)
21. Lacz NL, Schwartz RA, Kihiczak G. Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event. Int J Dermatol 2005; 44: 1-6. (Pubitemid 40201979)
22. Ruiz-Maldonado R, Tamayo-Sanchez L, Orozco-Covarrubias ML. The use of retinoids in the pediatric patient. Dermatol Clin 1998; 16: 553-569
23. Kempers S, Katz HI, Wildnauer R, Green B. An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkatosis and ichthyosis. Cutis 1998; 61: 347-350 (Pubitemid 128473129)
24. Vahlquist A, Gånemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol 2008; 88: 4-14. (Pubitemid 351212127)
25. Rugg EL. Therapeutic interference: a step closer for pachyonychia congenita? J Invest Dermatol 2008; 128: 7-8.